HER2 POSITIVE

Clinical trials for HER2 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2 POSITIVE trials appear

Sign up with your email to follow new studies for HER2 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug sequence aims to outsmart advanced breast cancer

Disease control Not yet recruiting

This trial tests a planned sequence of treatments for people with advanced or metastatic HER2-positive and hormone receptor-positive breast cancer. Participants first receive T-DXd (Enhertu) plus pertuzumab, then switch to a maintenance combination of palbociclib, endocrine thera…

Matched conditions: HER2 POSITIVE

Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC

HER2 POSITIVE

Get alerted when new HER2 POSITIVE trials appear

New drug sequence aims to outsmart advanced breast cancer